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E-mail address: hannoush.rami@gene.com (R.N. HPalmitoylation of the Wnt and Hedgehog proteins is critical for maintaining their physiological
functions. To date, there are no reported studies that characterize the cellular distribution of the
palmitoylated forms of these proteins. Here, we describe the subcellular localization of palmitoylat-
ed Wnt and Sonic Hedgehog by using a highly sensitive and non-radioactive labeling method that
utilizes alkynyl palmitic acid. We show that palmitoylated Wnt and Sonic Hedgehog localize to cel-
lular membrane fractions only, highlighting a role for palmitoylation in the membrane association
of these proteins. The method described herein has the utility to validate inhibitors of Wnt and
Hedgehog acyltransferases in drug discovery, and enables further investigations of the role of palm-
itoylation in the secretion and signaling of these proteins.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction tion factors [1]. While the palmitoylation sites of these proteinsThe Wnt and Hedgehog (Hh) pathways are critical regulators of
embryonic development and cancer stem cell differentiation [1].
Emerging evidence indicates that deregulation of Wnt or Hh sig-
naling is implicated in a number of human diseases. In particular,
Hh ligand overexpression is correlated with colon, pancreatic and
ovarian cancers [2,3]. Furthermore, activating mutations in the
Wnt pathway are associated with several cancer types, such as
breast, lung, colon and pancreatic [4,5].
Posttranslational palmitoylation of Wnt and Hh proteins regu-
lates their signaling activity. For example, palmitoylation of Wnt
is critical for the protein’s ability to bind to its cell surface Frizzled
receptors and initiate downstream signaling events leading to sta-
bilization of b-catenin [6,7]. To a lesser extent, palmitoylation of
Hh, together with cholesterol, permits it to bind to the cell surface,
which appears to mediate its interaction with the receptor Patched
to trigger activation of the downstream Gli zinc-ﬁnger transcrip-chemical Societies. Published by E
; Alk-C16,x-alkynyl palmitic
; IWP-2, inhibitor of Wnt
Dulbecco’s modiﬁed Eagle’s
albumin; DMSO, dimethyl
is(2-carboxyethyl)phosphine
-yl)methyl]amine
annoush).have been identiﬁed, how palmitoylation regulates their function
and localization at the molecular level is less well understood.
Protein palmitoylation involves the enzyme-catalyzed addition
of a 16-carbon saturated fatty acid to cellular proteins [8,9]. For
example, it has been shown that Wnt3a is palmitoylated at Cys
77 [10] and palmitoleoylated at Ser 209 [11]. Autoprocessing of
Shh leads to generation of an N-terminal fragment (Shh-N) that
undergoes concomitant cholesterol addition to its C-terminus
[12], and palmitoylation at its N-terminus [13]. To our knowledge,
there are no studies reported to date that characterize the cellular
distribution of the palmitoylated forms of these proteins. Earlier
studies utilizing site-directed mutagenesis combined with anti-
body detection and detergent phase separation methods revealed
that palmitoylation-defective mutants of Wnt and Hh partitioned
to the aqueous phase, while the wild-type proteins were present
in the detergent phase [6,10,13,14], though the nature of the mem-
branes is as yet unclear.
Our understanding of palmitoylation and its role in Wnt and Hh
signaling remains elusive. It is widely appreciated that signiﬁcant
challenges exist in detecting the palmitoylation status of these pro-
teins. This is in part due to the lack of robust non-radioactive meth-
ods that allow rapid detection of distinct lipid modiﬁcations on
Wnt or Hh in a routine manner. The use of radioactivity combined
with subcellular fractionation is cumbersome because of safety
hazards and long exposure times associated with autoradiography.lsevier B.V. All rights reserved.
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because of the technical complexities associated with the hydro-
phobic nature of lipid-modiﬁed peptides. To address these issues,
our lab has recently developed x-alkynyl fatty acid analogues as
tools for monitoring the lipid modiﬁcations of cellular proteins
[15]. Using this technique, which includes an x-alkynyl palmitic
acid probe (Alk-C16 [9,15], Fig. 1) combined here with immuno-
precipitation and subcellular fractionation, we report the non-
radioactive detection of palmitoylated Wnt and Sonic Hedgehog
(Shh) and describe their membrane attachment. The method de-
scribed herein is highly sensitive, speciﬁc, rapid and does not com-
prise the use of hazardous radioactive reagents.
2. Materials and methods
2.1. Cell culture
Mouse ﬁbroblast L-cells stably overexpressing Wnt3a (ATCC no.
CRL-2647) or human embryonic kidney (HEK) 293 cells stably
overexpressing Shh (Genentech) were grown in high glucose Dul-
becco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 0.4 mg/ml Geneticin and 2 mM
Glutamax™. All cells used were incubated in a 5% CO2 humidiﬁed
incubator at 37 C for 24 h before any experiments.Fig. 1. Scheme for metabolic labeling and biochemical detection of palmitoylated Wnt a
and is incorporated into fatty acylated proteins, denoted by colored ovals (step A). After
Cu(I)-catalyzed [3+2] cycloaddition (click) reaction (step B). The biotin-conjugated targe
(step C) and subsequently detected by streptavidin-conjugated infrared dye (step D),
conjugated secondary antibodies..2.2. Metabolic labeling of lipid modiﬁed proteins
x-alkynyl palmitic acid (Alk-C16) was synthesized as previ-
ously described [15]. It was dissolved in DMSO to a ﬁnal stock con-
centration of 50 mM and stored at -80 C. Before cell treatment,
Alk-C16 was diluted to a ﬁnal concentration of 100 lM in DMEM
supplemented with 5% BSA (fatty acid-free). The Alk-C16-contain-
ing medium was sonicated for 15 min at room temperature and
then allowed to precomplex for another 15 min. Cells were seeded
onto a 10 cm culture dish and incubated for 24 h before treatment.
After removal of the growth medium, cells were washed once with
PBS before addition of Alk-C16-containing medium (5 ml). After a
6 h incubation at 37 C/5% CO2, cells were washed three times with
cold PBS. For detection in total lysates, cell extracts were prepared
in 400 ll of lysis buffer (100 mM sodium phosphate, pH 7.5, 1%
Nonidet P-40, 150 mM NaCl, Pierce protease and phosphatase
inhibitor cocktail). Protein extracts (2 mg/ml) were then
subjected to the click labeling reaction in a 100 ll volume for 1 h
at RT at ﬁnal concentrations of the following reagents: 0.1 mM
biotin-azide, 1 mM Tris(2-carboxyethyl)phosphine hydrochloride
(TCEP, Sigma-Aldrich) dissolved in water, 0.2 mM Tris[(1-benzyl-
1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, Sigma–Aldrich) dis-
solved in DMSO/tert-butanol (20%/80%) and 1 mM CuSO4 in
water.nd Hedgehog proteins. x-Alkynyl palmitic acid (Alk-C16) is added to cultured cells
cell lysis, the alkynyl group is chemoselectively ligated to azide-tagged biotin by a
t Wnt or Hedgehog proteins are then immunoprecipitated with speciﬁc antibodies
with optional detection of total Wnt or Hedgehog using ﬂuorescent (Alexa680)-
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Cellular lysates were precipitated with 5 times volume of
ice-cold acetone, vortexed and incubated overnight at –20 C. The
mixture was centrifuged at 16 000g for 10 min at 4 C and the
supernatant was aspirated. The obtained pellet was air-dried for
5 min and then resuspended in 400 ll of lysis buffer. The lysates
were sonicated for 10 min and then incubated with a ﬁnal concen-
tration of 5 lg/ml of well-characterized anti-Wnt3a (ab28472,
Abcam) or anti-Shh (Murine 5E1 [16]; developed under the aus-
pices of the NICHD, National Institutes of Health and maintained
by the University of Iowa, Department of Biological Sciences, Iowa
City, IA) antibodies for 2 h at 4 C with rocking, and subsequently
immunoprecipitated with 40 ll of 1:1 mixture of protein-A
(P2545, Sigma): protein-G (P3296, Sigma) sepharose beads with
rocking for 1 h at 4 C. The beads were washed six times with
PBS containing 0.1% Tween-20 (PBST). They were then resus-
pended in 40 ll of lysis buffer containing SDS sample buffer and
dithiothreitol (50 mM), heated for 5 min at 95 C and resolved by
SDS–PAGE.
2.4. Pull-down of Wnt3a from conditioned medium
Wnt3a conditioned medium was collected from L-Wnt3a cells
that had been treated with Alk-C16 or DMSO for 48 h. The medium
was incubated with 40 ll Blue Sepharose beads (17-0948-02, GE
Healthcare Biosciences) on a rocking platform for 2 h at 4 C. The
beads were washed 6 times with PBST. Lysis buffer containing
SDS sample buffer and 50 mM dithiothreitol (40 ll) was added to
the beads and the mixture was heated at 95 C for 5 min before
being resolved on SDS–PAGE.
2.5. Cellular fractionation
Cells that had been metabolically labeled with Alk-C16 were
fractionated as previously described [17]. Brieﬂy, cells were
washed twice with cold HEPES buffer (150 mM NaCl, 50 mM
HEPES, pH 7.4), scraped off the tissue culture plates using a cell lif-
ter, and collected. Cells were spun down at 1000g for 10 min,
resuspended in 10 ml of hypotonic buffer (10 mM NaCl, 1.5 mM
MgCl2, 10 mM HEPES pH 7.4 with EDTA-free complete protease
inhibitors) for 20 min on ice, and then homogenized using a Doun-
ce homogenizer (30 strokes). The homogenate was centrifuged at
1000g for 5 min at 4 C and the postnuclear supernatant was col-
lected. The pellet (nuclear fraction) was washed three times with
HEPES buffer containing EDTA-free protease inhibitors (Pierce).
The postnuclear supernatant was further centrifuged at
100 000g for 30 min at 4 C, yielding the cytosolic fraction (super-
natant) and the membrane fraction (pellet). The pellet was washed
three times with HEPES buffer containing EDTA-free complete pro-
tease inhibitors. Both the membrane and nuclear fractions were
solubilized in HEPES buffer containing EDTA-free complete prote-
ase inhibitors and 1% SDS. The cytosolic fraction was also adjusted
to 1% SDS. The protein concentration of all fractions was deter-
mined by the BCA assay (Thermo Scientiﬁc) according to manufac-
turer’s recommendations. Protein extracts (0.7 mg/ml) were then
subjected to the probe labeling reaction in a 100 ll volume, for
1 h at RT as described above.
2.6. Western blot
Labeled protein lysates or immunoprecipitated proteins were
resolved by SDS–PAGE using 4–20% Tris-glycine gels. For immuno-
blotting of biotin-labeled proteins after electrophoresis, proteins
were transferred onto a nitrocellulose membrane, which was
subsequently blocked with Odyssey Blocking Buffer overnight at4 C. The membrane was incubated with primary antibodies
(anti-Wnt3a (ab28472), Abcam, 1:500; anti-Shh H-160 (sc-9024),
Santa Cruz Biotechnology, 1:500; anti-Tim23 (611222), BD Biosci-
ences, 1:2000; anti-GAPDH (2118) and anti-Lamin A/C (2032), Cell
Signaling, both 1:500) in Odyssey Blocking Buffer for 1 h at RT. The
membrane was washed three times with PBST (10 min each) and
incubated with Alexa680-conjugated secondary antibodies in
Odyssey Blocking Buffer containing 0.1% Tween-20 and 0.01%
SDS. The membrane was then washed three times with PBST
(10 min each). For detection of biotin-labeled proteins, the mem-
brane was incubated with streptavidin-conjugated IRDye800 in
Odyssey Blocking Buffer containing 0.1% Tween-20 and 0.01%
SDS, then washed three times with PBST (10 min each). Total pro-
teins were visualized in the 700 nm channel and biotin-labeled
proteins were visualized in the 800 nm channel on an Odyssey
Infrared Imager.
2.7. Cell-based Hh reporter assay
Hh signaling was measured using stably transfected Gli-lucifer-
ase reporter S12 cells as described previously [18]. Brieﬂy, 10 000
S12 cells/well were plated on a white-walled clear-bottomed 96-
well plate (Costar 3610) in regular growth medium (DMEM, 10%
(v/v) FBS, 2 mM L-glutamine) for 24 h, and 20 000 HEK 293 cells
stably overexpressing Shh were then co-cultured on top for 24 h,
followed by 24 h of serum starvation (0.5% (v/v) FBS) in the pres-
ence of Alk-C16 (100 lM) or an equivalent volume of DMSO, prior
to luciferase measurement (HTS SteadyLite kit, Perkin–Elmer Life
Sciences).
2.8. Cell-based Wnt signaling activity assay
Wnt3a signaling was reported by measuring b-catenin levels in
L- and L-Wnt3a cells as described previously [19]. Brieﬂy, L or
L-Wnt3a cells (5000 cells/20 ll/well) were seeded in a clear bot-
tomed, black walled 384-well plate and grown for 24 h. Alk-C16
(20 ll), diluted in DMEM supplemented with 5% BSA (fatty acid-
free), was added to a ﬁnal concentration of 100 lM. After overnight
incubation, the cells were ﬁxed in 4% PFA by adding 20 ll of 12%
PFA directly to the wells for 1 h at room temperature, permeabili-
zed with PBS/0.1% Triton X-100 for 5 min, then blocked in Odyssey
Blocking Buffer (50 ll/well) for 2 h at room temperature. The wells
were incubated with mouse anti-b-catenin antibody (610154, BD
Biosciences, 1: 200) in Odyssey Blocking Buffer for 2 h at room
temperature (20 ll/well) and subsequently washed with PBST.
Infrared anti-mouse IRDye800CW secondary antibody (1: 200)
and DRAQ5 (1:10 000, Biostatus) in PBS/0.5% Tween-20 were then
added (20 ll/well). The plates were incubated for 1 h at room tem-
perature, and the wells were washed with PBST and incubated in
PBS (50 ll/well). The plates were covered with black seals and
imaged on an Odyssey infrared scanner.3. Results and discussion
To probe palmitoylation of Wnt or Shh proteins, mouse ﬁbro-
blast L-cells that stably express Wnt3a or human embryonic kid-
ney (HEK) 293 cells that stably express Shh were incubated for
6 h with Alk-C16, a probe established earlier for the metabolic
labeling of all cellular palmitoylated proteins [15,20–22]. The cells
were then lysed, and the alkynyl-labeled palmitoylated proteins
were chemoselectively ligated to azide-tagged biotin by a Cu(I)-
catalyzed alkyne-azide [3+2] Huisgen cycloaddition reaction
[15,23]. Total proteins were then precipitated to remove excess
chemical reagents and the pellets were resuspended in lysis buffer.
Wnt3a or Shh were subsequently immunoprecipitated using
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groups were detected by western blotting using streptavidin-
conjugated IRDye800 near-infrared dye (Fig. 1).
Several major bands corresponding to Wnt3a were detected
around 39 kDa, in agreement with its expected molecular weight
(Fig. 2A). The multiple bands reﬂect the complex nature of the mul-
tiple post-translational modiﬁcations that exist on Wnt3a (see be-
low). No labeling was observed in samples treated with DMSO,
thereby yielding an excellent signal to background ratio. Moreover,
the palmitate labeling of theWnt3a bands with Alk-C16 was lost in
the presence of a 5-fold molar excess of unlabeled palmitic acid,
illustrating the speciﬁcity of the labeling reaction (Fig. 2A). More
importantly, we ﬁnd that Wnt3a labeled with Alk-C16 is secreted
properly and detected in conditioned media to the same degree
as the DMSO control (Fig. 2B). Consistent with this notion, andFig. 2. Detection of the palmitoylated forms of Wnt3a and Sonic Hedgehog. Mouse L-cells
with either DMSO or Alk-C16 in the absence or presence of a ﬁve-fold molar excess of
reaction, Wnt3a or Shh were immunoprecipitated, resolved by SDS–PAGE and immunobl
conjugated anti-rabbit secondary antibodies and streptavidin-conjugated IRDye800 (for d
are detected at 39 kDa, while a band corresponding to Shh-N is detected at 19 kDa in
and lane 3 (E), respectively. (B) Alk-C16 labeled Wnt3a is secreted properly into conditio
Alk-C16 using Blue Sepharose. The same level of secreted Wnt3a was detected from Alk-
Wnt3a signaling. Wnt3a signaling activity was reported by measuring the total level of b
difference between DMSO and Alk-C16 treatment is observed (n = 8). To account for m
intensity. (D) Palmitoylation of Wnt3a is inhibited by IWP-2 or BPA treatment. L-Wnt3
(500 lM) IWP-2 (10 lM). (F) Treatment with Alk-C16 does not interfere with Shh sig
reporter S12 cells, co-cultured with HEK293 cells stably overexpressing Shh, in the prese
between DMSO and Alk-C16 treatment is observed (n = 6).using a cell-based Wnt signaling activity assay [19], we further
demonstrate that Alk-C16 treatment has no adverse effects on
Wnt3a-mediated stabilization of b-catenin (Fig. 2C), indicating that
Alk-C16-labeled Wnt3a retains its signaling activity.
We observe that most, if not all, of the immunoprecipitated
Wnt3a bands are labeled with Alk-C16, indicating the presence
of multiple palmitoylated species of Wnt3a (Fig. 2A). This can be
explained in light of previous ﬁndings that clearly showed that
Wnt3a can be glycosylated at several sites [6]. Given that N-linked
glycosylation of Wnt3a appears to be necessary for its palmitoyla-
tion [6,24], it is conceivable that some of the non-palmitoylated
Wnt3a bands contain few or no glycan modiﬁcations. Overall, the
global biochemical proﬁle revealed here provides insight into the
diverse population of palmitoylated Wnt3a that exists in the cell.
To further interrogate the scope of this novel labeling method,stably expressing Wnt3a (A) or HEK293 cells stably expressing Shh (E) were treated
unlabeled palmitic acid (PA) for 6 h. After preparation of the cell lysates and click
otted with anti-Wnt3a (A) or anti-Hh (E) primary antibodies, followed by Alexa680-
etection of biotin-conjugated palmitoylated Wnt3a and Shh). Multiple Wnt3a bands
all samples. For palmitoylated Wnt3a or Shh-N labeled with Alk-C16, see lane 2 (A)
ned media. Wnt3a was puriﬁed from conditioned media containing either DMSO or
C16 or DMSO containing media. (C) Treatment with Alk-C16 does not interfere with
-catenin in the presence of DMSO or Alk-C16 in L- and L-Wnt3a cells. No signiﬁcant
inor differences in cell numbers, the b-catenin signal is normalized to DNA signal
a cells were incubated overnight with Alk-C16 in the absence or presence of BPA
naling. Hh signaling activity was measured using stably transfected Gli-luciferase
nce of DMSO or Alk-C16, prior to luciferase measurement. No signiﬁcant difference
X. Gao et al. / FEBS Letters 585 (2011) 2501–2506 2505we took a pharmacological approach to assess whether it can be
used to identify Wnt palmitoylation inhibitors. IWP-2 is an inhib-
itor of Wnt palmitoylation that functions by targeting Porcupine,
an acyltransferase speciﬁcally responsible for Wnt3a palmitoyla-
tion [25], while bromopalmitic acid (BPA) is an inhibitor of total
cellular palmitoylation. Treatment with either IWP-2 or BPA abol-
ished palmitoylation of Wnt3a (Fig. 2D), as expected, further con-
ﬁrming the speciﬁcity of our labeling method. Together these
data indicate that this method has the potential to be used for
developing and validating inhibitors of Wnt acyltransferases, and
also for dissecting the temporal dynamics of palmitoylation of
Wnt and its role in signaling.
In cells expressing Shh, we detect a 19 kDa band that corre-
sponds to the cleaved N-terminal fragment of Shh (Shh-N,
Fig. 2E) but no 45 kDa band corresponding to full-length Shh
(data not shown). Treatment with Alk-C16 leads to the appearance
of a single band that corresponds to palmitoylated Shh-N and is
shifted to a higher molecular weight of approximately 22 kDa
(Fig. 2E). This band is absent in the DMSO control and can be com-
peted with excess palmitic acid (Fig. 2E), demonstrating speciﬁcity
of the metabolic labeling reaction. However, only a fraction of the
total immunoprecipitated band shifted, indicating that the palmi-
tate labeling reaction is incomplete. This is most likely because
Shh is unique in being palmitoylated via an irreversible amide
bond rather than a thioester linkage [26], thus only non-palmitoy-
lated Shh should be a substrate for Alk-C16. Additionally, there was
no shift in the presence of excess unlabeled palmitate, indicating
that it is the biotin (244 Da) conjugation rather than the palmitate
(238 Da) per se that increases the apparent molecular weight. Fur-
thermore, using a cell-based Hh reporter assay [18], we demon-
strate that treatment with Alk-C16 has no adverse effects on Hh
signaling (Fig. 2F). Overall, our data show that there exist two dis-
tinct populations of Shh, one that is represented by the palmitoy-
lated upper band (labeled with Alk-C16) and the other
represented by the lower band that is not labeled with Alk-C16.
It is noteworthy that the current labeling method offers the advan-
tage of visualizing both palmitoylated and total protein bands on
the same gel, making it easy to differentiate superimposed or clo-
sely migrating bands.
The physiological function of protein palmitoylation is still not
well understood. Acyltransferases that regulate palmitoylation ofFig. 3. Palmitoylated Wnt3a and Shh are exclusively detected in the cellular membrane fr
were fractionated into cytosolic (C), membrane (M), and nuclear (N) fractions. Each fract
being probed with markers speciﬁc for these compartments, GAPDH, Tim23 and Lam
predominantly enriched in the membrane fraction and palmitoylated Wnt3a is exclusiv
expressing Shh were processed as in (A), immunoprecipitated and detected by immunob
cytosolic fractions.Wnt and Shh have been shown to be likely present in the lumen
of the endoplasmic reticulum and/or Golgi apparatus [24,26].
These interesting observations prompted us to investigate the sub-
cellular distribution of the palmitoylated forms of Wnt and Shh. To
address this, we performed cellular fractionation of samples trea-
ted with Alk-C16. The cytosolic, membrane, and nuclear fractions
obtained by differential centrifugation were probed with markers
that are speciﬁc to these fractions such as GAPDH, Tim23, and
Lamin A/C, respectively (Fig. 3). We ﬁnd that total Wnt3a is highly
enriched in the membrane fraction, with a minor subpopulation
present in the cytosolic and nuclear fractions (Fig. 3A). More
importantly, the palmitoylated form of Wnt3a is only found in
the membrane fraction (Fig. 3A). The absence of palmitoylated
Wnt3a from the cytosolic fraction reveals the pivotal role that
palmitoylation plays in directing the association of Wnt3a with
membrane-bound compartments. Collectively, our studies enable
further investigation into the distribution of the palmitoylated
form of Wnt3a across cellular membrane compartments.
We ﬁnd that total Shh-N and palmitoylated Shh-N were present
in the cellular membrane but not cytosolic fractions (Fig. 3B). It is
striking that the lower Shh-N band not labeled with Alk-C16 is
present in the membrane fraction. This could be either because
the lower band was already irreversibly palmitoylated (and hence
not accessible to the Alk-C16 labeling), or because palmitoylation
is dispensable for Shh targeting to this compartment, as expected
from the ability of the C-terminal cholesterol group to mediate
membrane tethering [12]. The latter is consistent with earlier
genetic studies demonstrating that a palmitoylation-defective
mutant of Shh (Cys25Ser) is associated with lipid raft fractions in
HEK293 cells [14]. All together, our data further support the
existence of mechanisms other than palmitoylation, such as cho-
lesterylation, that target Shh to membrane-bound compartments.
In summary, we report here the development of a facile and
highly sensitive non-radioactive method to detect palmitoylation
of Wnt and Hedgehog proteins. Furthermore, we characterized
the unique subcellular distribution patterns of palmitoylated
Wnt3a and Shh. The strong preference of palmitoylated Wnt3a
and Shh towards localizing to cellular membrane compartments
highlights membrane anchoring as one of the central functions of
palmitoylation in these signaling pathways. While this manuscript
was in preparation, a method for probing cholesterol modiﬁcationaction. (A) Cell extracts of L-cells stably expressing Wnt3a and treated with Alk-C16
ion was subjected to immunoprecipitation followed by immunoblotting, as well as
in A/C, respectively. 3% of each fraction was loaded in each lane. Total Wnt3a is
ely detected in the membrane fraction. (B) Cellular extracts of HEK293 cells stably
lotting. Both Shh-N and palmitoylated Shh-N are detected in the membrane but not
2506 X. Gao et al. / FEBS Letters 585 (2011) 2501–2506of Shh by using a bio-orthogonal cholesterol analogue was
reported [27]. The study did not describe the membrane distribu-
tion of cholesterylated Shh; however this promising technique
could allow for similar studies to examine the importance of
cholesterol for directing Shh localization.
Wnt and Hh are attractive targets for the development of anti-
cancer therapeutics [28,29]. Recent reports show that inhibition of
Wnt3a palmitoylation by targeting the acyltransferase activity of
Porcupine may be a viable strategy to counteract aberrant Wnt sig-
naling [25]. Given its highly sensitive and non-radioactive nature,
the method described herein has the utility to validate the mecha-
nism of small molecule inhibitors of palmitoylation in drug discov-
ery. Also, it facilitates investigation of the subcellular distribution
of palmitoylated Wnt and Shh, and it enables further studies of
the role of palmitoylation in the secretion and signaling activity
of these proteins.
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